HOME >> BIOLOGY >> NEWS
'PET/CT in Cancer Patient Management' examined in Journal of Nuclear Medicine Supplement

RESTON, Va. -- "PET/CT in Cancer Patient Management" is the subject of a special supplement to the January issue of the Journal of Nuclear Medicine. SNM, the largest molecular imaging and nuclear medicine association, is publishing a unique collection of articles that explores the role of 18F-FDG PET/CT imaging in patient screening, cancer diagnosis, initial treatment planning, treatment monitoring and detection of early recurrence.

"Oncologists, internists, general practitioners, radiologists and nuclear medicine physicians are frequently overwhelmed by the need to select--from among the different imaging modalities--the one that best serves the needs of their patients," notes the supplement's guest editor Johannes Czernin, the director of the Nuclear Medicine Clinic and professor and vice chair of molecular and medical pharmacology at the University of California, Los Angeles. "Despite the impressive growth of PET/CT, there is no consensus on the optimum clinical use of PET/CT and its implementation into patient management," he added, thereby prompting the publication of this exceptional resource.

"Selecting the 'best' PET/CT protocol for a given clinical problem adds another layer of complexity for referring physicians and practicing imaging specialists who need to avoid redundancies in diagnostic tests that frequently involve radiation," said Heinrich Schelbert, who is editor in chief of JNM, the most prominent peer-reviewed journal in nuclear medicine, molecular imaging and allied disciplines.

Doctors use positron emission tomography (PET) and computed tomography (CT) scans as standard imaging tools to pinpoint disease states in the body. When PET is used to image cancer, a radiopharmaceutical (such as fluorodeoxyglucose or FDG, which includes both a sugar and a radionuclide) is injected into a patient. Cancer cells metabolize sugar at higher rates than normal cells, and the radiopharmaceutical is drawn in higher concentrations
'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-652-6773
Society of Nuclear Medicine
2-Jan-2007


Page: 1 2 3 4

Related biology news :

1. Journalists can register now for ECCO 14 -- the European Cancer Conference
2. Cancer cures could work for canines and humans
3. The Cancer Genome Atlas awards funds for technology development
4. Cancer research specialist and HSPH professor awarded Medal of Honor from WHO cancer agency
5. Cancer stem cells similar to normal stem cells can thwart anti-cancer agents
6. Cancer stem cells can go it alone
7. Cancer drug enhances long-term memory
8. Cancer cells reprogram energy needs to grow and spread, study suggests
9. Cancer scientists create human leukemia process to map how disease begins, progresses
10. Cancer tip -- Nanoparticles can damage DNA, increase cancer risk
11. Other highlights from the April 18 Journal of the National Cancer Institute

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/19/2020)... ... 2020 , ... The director of stem cell biotechnology company Asymmetrex , ... and pharmaceutical industries have easier access to stem cell counting, they will soon make ... year, Independence Day weekend in the U.S., Asymmetrex is offering free tissue stem cell ...
(Date:6/13/2020)... ... 2020 , ... Bode Technology (Bode), a leading ... team. Bode’s Forensic Genealogy Service (FGS) continues to deliver investigative leads ... The team has added experienced genealogists, each having over a decade of field ...
(Date:6/5/2020)... ... 04, 2020 , ... Murrieta Genomics has announced that its wholly ... sample preparation for Next Generation Genomic Sequencing (NGS) . This is the third ... of sample preparation. , “I have been at the bench for over 20 years,” ...
Breaking Biology News(10 mins):
(Date:6/11/2020)... ... June 09, 2020 , ... TRX Systems, ... NEON Micro-Tracer Solution, a highly accurate, contact tracing solution for identification of ... Contact tracing, a core disease control measure, is a key strategy for preventing ...
(Date:6/2/2020)... ... June 01, 2020 , ... As part ... positive change in the world, enterprise security solutions provider bitsIO donated time to ... working from home during self-quarantines and shelter-in-place orders, companies are increasingly concerned about ...
(Date:5/28/2020)... , ... May 28, 2020 , ... ... today announced the release of Genedata Screener ® 17.0, the latest version ... data from all in-vitro screening assay technologies. Genedata will host a webinar on ...
(Date:5/21/2020)... (PRWEB) , ... May 21, 2020 , ... ... of clinical trials will cause long-term harm , Contrary to conventional wisdom that ... Institute study finds many companies will emerge from the pandemic commercially weaker, ...
Breaking Biology Technology:
Cached News: